These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 8089650)

  • 1. Erythroid 5-aminolevulinate synthase and X-linked sideroblastic anemia.
    Ferreira GC
    J Fla Med Assoc; 1993 Jul; 80(7):481-3. PubMed ID: 8089650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis.
    May BK; Bhasker CR; Bawden MJ; Cox TC
    Mol Biol Med; 1990 Oct; 7(5):405-21. PubMed ID: 2095458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase.
    Cox TC; Bottomley SS; Wiley JS; Bawden MJ; Matthews CS; May BK
    N Engl J Med; 1994 Mar; 330(10):675-9. PubMed ID: 8107717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models for X-linked sideroblastic anemia.
    Yamamoto M; Nakajima O
    Int J Hematol; 2000 Aug; 72(2):157-64. PubMed ID: 11039663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia.
    Bottomley SS; May BK; Cox TC; Cotter PD; Bishop DF
    J Bioenerg Biomembr; 1995 Apr; 27(2):161-8. PubMed ID: 7592563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress in iron metabolism and iron-related anemia].
    Harigae H
    Rinsho Byori; 2010 Dec; 58(12):1211-8. PubMed ID: 21348241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
    Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
    Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Aminolevulinate synthase in sideroblastic anemias: mRNA and enzyme activity levels in bone marrow cells.
    Bottomley SS; Healy HM; Brandenburg MA; May BK
    Am J Hematol; 1992 Oct; 41(2):76-83. PubMed ID: 1415186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations.
    Ducamp S; Kannengiesser C; Touati M; Garçon L; Guerci-Bresler A; Guichard JF; Vermylen C; Dochir J; Poirel HA; Fouyssac F; Mansuy L; Leroux G; Tertian G; Girot R; Heimpel H; Matthes T; Talbi N; Deybach JC; Beaumont C; Puy H; Grandchamp B
    Hum Mutat; 2011 Jun; 32(6):590-7. PubMed ID: 21309041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia.
    Fujiwara T; Harigae H
    Free Radic Biol Med; 2019 Mar; 133():179-185. PubMed ID: 30098397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic rescue of erythroid 5-aminolevulinate synthase-deficient mice results in the formation of ring sideroblasts and siderocytes.
    Nakajima O; Okano S; Harada H; Kusaka T; Gao X; Hosoya T; Suzuki N; Takahashi S; Yamamoto M
    Genes Cells; 2006 Jun; 11(6):685-700. PubMed ID: 16716198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
    Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
    J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress of study on sideroblastic anemia and its possible gene therapy--review].
    Wang YQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):524-8. PubMed ID: 15972158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-aminolevulinate synthase: catalysis of the first step of heme biosynthesis.
    Hunter GA; Ferreira GC
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):102-10. PubMed ID: 19268008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythroid 5-aminolevulinate synthase is located on the X chromosome.
    Cox TC; Bawden MJ; Abraham NG; Bottomley SS; May BK; Baker E; Chen LZ; Sutherland GR
    Am J Hum Genet; 1990 Jan; 46(1):107-11. PubMed ID: 2294742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
    Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
    Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple mechanisms for hereditary sideroblastic anemia.
    Furuyama K; Sassa S
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):5-10. PubMed ID: 11929048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular permutation of 5-aminolevulinate synthase as a tool to evaluate folding, structure and function.
    Ferreira GC; Cheltsov AV
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):11-6. PubMed ID: 11929042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arg452 substitution of the erythroid-specific 5-aminolaevulinate synthase, a hot spot mutation in X-linked sideroblastic anaemia, does not itself affect enzyme activity.
    Furuyama K; Harigae H; Heller T; Hamel BC; Minder EI; Shimizu T; Kuribara T; Blijlevens N; Shibahara S; Sassa S
    Eur J Haematol; 2006 Jan; 76(1):33-41. PubMed ID: 16343269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human delta-aminolevulinate synthase: assignment of the housekeeping gene to 3p21 and the erythroid-specific gene to the X chromosome.
    Bishop DF; Henderson AS; Astrin KH
    Genomics; 1990 Jun; 7(2):207-14. PubMed ID: 2347585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.